Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Xechem Buys Ceptor, Adds Size To Niche Drug Pipeline

Dec. 31, 2003

By Aaron Lorenzo

Arena Raises $35M Through Sale Of Preferred Convertible Shares

Dec. 30, 2003

By Aaron Lorenzo

Arena Raises $35M Through Sale Of Preferred Convertible Shares

Dec. 30, 2003

By Aaron Lorenzo

Inspire Gets Approvable Letter Asking For More Diquafosol Data

Dec. 23, 2003

By Aaron Lorenzo

Inspire Gets Approvable Letter Asking For More Diquafosol Data

Dec. 23, 2003

By Aaron Lorenzo

Pharmacopeia Plans To Divide Drug Discovery, Software Units

Dec. 22, 2003

By Aaron Lorenzo

Pharmacopeia Plans To Divide Drug Discovery, Software Units

Dec. 22, 2003

By Aaron Lorenzo

Sequenom, P&G Enter $30M Agreement For Osteoporosis

Dec. 19, 2003

By Aaron Lorenzo

Sequenom, P&G Enter $30M Agreement For Osteoporosis

Dec. 19, 2003

By Aaron Lorenzo

FDA Receives Supplemental NDA For Fuzeon From Trimeris, Roche

Dec. 17, 2003

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 10, 2025
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...
Australia’s Celosia heads toward clinic with gene therapy for ALS
BioWorld
After raising AU$16.75 million (US$10.4 million) in a series A round, Celosia Therapeutics Pty Ltd. is heading toward the clinic with its novel gene therapy that...
Sangamo stock plunges as Pfizer leaves hemophilia partnership
BioWorld
Sangamo Therapeutics Inc.’s stock sank sharply on the last day of 2025 as Pfizer Inc. handed back the rights to their collaborative gene therapy hemophilia A...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.